Implications of a Circulating Vaccine-Derived Poliovirus in Nigeria

2010133 citationsJournal Articlebronze Open Access

Authors

Helen E. Jenkins · Medical Research Council

R. Bruce Aylward

Alex Gasasira · World Health Organization - Nigeria

Christl A. Donnelly · Imperial College London

Michael Mwanza · World Health Organization - Nigeria

Jukka Corander · University of Helsinki

Sandra Garnier

Claire Chauvin

Abstract

The attack rate and severity of disease associated with the recent cVDPV identified in Nigeria are similar to those associated with WPV. International planning for the management of the risk of WPV, both before and after eradication, must include scenarios in which equally virulent and pathogenic cVDPVs could emerge.

Topics & Keywords

Viral Infections and Immunology Research Viral gastroenteritis research and epidemiology SARS-CoV-2 and COVID-19 Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 362, Issue 25, pp. 2360-2369

DOI: 10.1056/nejmoa0910074

Field-Weighted Citation Impact: 10.09